When could retatrutide availability begin?

Can you get approved retatrutide today?

You can't get approved retatrutide today. Tests continue, but the FDA and other drug agencies haven't cleared it anywhere. Only a person accepted into a study may receive drug made for that study.

Pharmacy access needs good Phase 3 results, a full request from the maker, and approval from a drug agency. That work isn't done. A seller calling online powder an approved prescription drug is making a false claim. Powder marked "for research only" sits outside the approved drug system. A clean label still can't show you whether the vial holds the named drug.

What happens in each numbered study phase?

A new drug normally passes four study phases before sale. Retatrutide hasn't finished them.

Phase 1, 2019–2022: Phase 1 is the first safety check. The first study watched healthy people and measured the drug's time in their blood ^[11]. A later small study followed adults with type 2 diabetes. Half the drug had left the blood after about six days. The highest-amount group lost 8.96 kilograms beyond the loss with placebo after 12 weeks ^[4]. Those findings allowed larger tests.

Phase 2, 2022–2023: Phase 2 asks whether a drug seems to work. These studies covered obesity ^[1] and type 2 diabetes ^[2]. Average weight fell 24.2 percent in 48 weeks in the obesity study ^[1]. In the diabetes study, it fell 16.94 percent in 36 weeks ^[2]. The blood test showing about three months of sugar fell 2.02 percent ^[2]. Those findings supported a move to Phase 3. Another Phase 2 study found a large drop in liver fat ^[5].

Phase 3, from 2023: Phase 3 checks more people for help and harm. The obesity study is called TRIUMPH-1 ^[7]. TRIUMPH-3 includes people with heart disease ^[8]. A third study follows heart and kidney health ^[9]. A fourth compares retatrutide with tirzepatide ^[10]. These Phase 3 studies can take 18–36 months and include thousands of people. Main results weren't all public by mid-2026.

After Phase 3: Eli Lilly must send all findings to the FDA. The facts must support its request. A standard FDA review often takes 6–12 months. Faster review may happen, but it can't promise approval or a date for you. Your plans can't safely rest on that clock.

When will retatrutide be available if approved?

No one knows. In mid-2026, Phase 3 visits and checks were still under way. The results may not match Phase 2. A rare harm may appear when more people take part. Study doctors may also need more time.

In 2026, some writers guessed that the maker might ask for approval in 2027. Eli Lilly didn't make that promise. Even good Phase 3 results wouldn't set a sale date. We won't turn a guess into a date you might trust. Your calendar needs firmer news before you rely on it.

Could a study give you access to retatrutide?

Yes, if a study accepts you. Staff check your weight, health problems, and distance from a study site. Those rules decide who may join. If accepted, you may get retatrutide at no cost while doctors watch your health. The ClinicalTrials.gov listings give the rules, sites, and people to contact ^[7][8].

We aren't tied to Eli Lilly or a study site. We can't place you in a study. Use ClinicalTrials.gov for current contact details. A listing doesn't mean you'll qualify.

Why is retatrutide powder sold online risky?

You can't know what fills an online vial. Retatrutide marked "for research only" has no approval or legal prescription route. No drug agency confirms its name, strength, or lack of germs. During 2025, more than fifty sellers got FDA warnings for breaking federal drug law. Tests of powders with similar labels found only pieces of the claimed drug, material changed by chemicals, or a different substance. A shot with germs can cause infection.

We don't link to sellers or rate them. We also won't help you get the powder. A label doesn't prove what's inside, and home mixing can't add the safety checks a real study gives you.